Last deal

$2.8M

Amount

Series A

Stage

20.01.2023

Date

2

all rounds

$182.8M

Total amount

General

About Company
Ignis Therapeutics develops innovative therapies for the central nervous system.

Industry

Sector :

Subsector :

founded date

01.01.2019

Company Type

For Profit

Last funding type

Series A

IPO status

Private
Contacts